Back to search results
NCT05082077

Global Utilization And Registry Database for Improved preservAtion of doNor Livers

Enrolling by Invitation
Not specifiedAges 18+Observational
Paragonix Technologies
~1,000 participants
Updated 2025-05-15 on ClinicalTrials.gov
What's tested:LIVERguard

At a glance

Recruiting sites
0 of 7 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Graft Failure
Measured over Post-transplant through 1 year post
+6 more outcomes measured

Conditions

Liver Diseases
Liver Dysfunction
Liver Transplant Disorder
Liver Transplant Rejection

Explore related trials

Liver TransplantationLiver transplant disorderLiver transplant rejection

Where it's being run

7 sites across 6 states
Florida2
Alabama1
California1
Nebraska1
North Carolina1
Washington1

Study leadership

  • Jason Vanatta, MD · PRINCIPAL_INVESTIGATOR · Methodist Le Bonheur Healthcare

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Donor and donor liver matched to the recipient based upon institutional medical practice
Registered male or female primary liver transplant candidates

Exclusion

Donor and donor liver that do not meet institutional clinical requirements for transplantation
Living donors
Pediatric recipients (under 18)

What this trial measures

  • Graft FailurePost-transplant through 1 year post

    The percentage of subjects in each cohort who develop graft failure post-transplant

  • Early allograft dysfunction7 days post transplant

    The percentage of subjects in each cohort who early allograft failure post-transplant

  • RejectionPost-transplant through 1 year post

    The percentage of subjects in each cohort who experience rejection post-transplant

  • Primary Non-functionPost transplant to 7 days post-transplant

    The percentage of subjects in each cohort who experience primary non-function post-transplant

  • SurvivalTransplant through 1 year post-transplant

    The percentage of subjects in each cohort who survive through 1 year post-transplant

  • Length of Stay1 year

    How many days the patient stays in the hospital post-transplant

  • Length of ICU stay1 year

    How many days the patient stayed in the ICU post-transplant